Recipient
Virica BiotechDepartment
National Research Council CanadaAmount
$304.7K
Province
ONType
C
Agreement Number
1019804
Purpose
As part of the international consortium project "Viral Enhancers - Development of small molecule formulations for enhanced production of AAV", this project will focus on developing and demonstrating at scale small molecule formulation(s) which increase the yield of next-generation gene therapies. Development of such technologies will enable faster clinical and commercial development of life saving technologies while simultaneously improving patient access through reduction of cost per dose.
Virica Biotech × National Research Council Canada
8 grants totalling $1.2M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $111.3M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $10.0M | Industrial Research Assistance Program –... |
| Laurent Thérapeutiques | $10.0M | Industrial Research Assistance Program –... |